title: [New therapeutic strategies in influenza infections in patients at risk. Controlled study of ribavirin].
authors.forename: M
authors.initials: M
authors.lastname: Pellegrino
authors.forename: E V
authors.initials: EV
authors.lastname: Baldini
authors.forename: M G
authors.initials: MG
authors.lastname: Amorico
authors.forename: A
authors.initials: A
authors.lastname: Bisetti
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000139:chemically induced; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D011897:Random Allocation; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D012307:Risk Factors
chemical_list: D012263:Ribonucleosides; D012254:Ribavirin
vernacular_title: Nuove strategie terapeutiche per l'infezione influenzale nel paziente a rischio. Indagine controllata sulla ribavirina.